Tags: influenza

Flu and COVID vaccines are prepared at Boston city hall on January 7, 2026. - Suzanne Kreiter/The Boston Globe via Getty Images

Leading U.S. Medical Organizations Issue 2026-27 Respiratory-Virus Vaccination Guidance

Leading U.S. medical organizations, including the AMA, AAP, AAFP, ACOG, and IDSA—in coordination with the University of Minnesota’s Vaccine Integrity Project—released updated guidance on Wednesday recommending influenza, COVID-19, and RSV immunizations for the upcoming fall and winter season, filling a gap as the CDC had not yet issued its own updated guidance amid shifting federal advice under the Trump administration. The recommendations call for flu vaccination for everyone aged 6 months and older, COVID-19 shots that some groups say go beyond current federal advice, and RSV immunizations tailored by age, pregnancy status, and risk factors, with updated COVID-19 vaccines already arriving after FDA approval and flu and COVID-19 infections rising as schools reopened.

The Managed Narrative Takes Control

You’re watching a pivot that feels procedural, but it’s anything but. When a coalition of medical groups—the AMA, the AAP, the ACOG—issues its own vaccine guidance before the CDC has even spoken, you are witnessing an explicit power transfer. The CDC, once the gold standard for public health authority, has been sidelined, not by incompetence but by design. These organizations, many of which are funded by the same foundations that sit on the boards of pharmaceutical conglomerates, are now acting as a shadow federal health body. They are not filling a void; they are establishing a parallel infrastructure for decision-making that bypasses elected accountability. The University of Minnesota’s “Vaccine Integrity Project” is the academic seal on a managed message. Ask yourself who funds that project. The answer leads you back to the same network of globalist NGOs that have been consolidating control over every lever of public consent for decades.

The Timing Is the Tell

Notice the rhythm. The FDA approved new COVID-19 formulations last week. Now, immediately, as flu and COVID infections begin their seasonal rise, these groups release their recommendations. This is not reactive public health; this is perception shepherding. They want you to believe that the threat is natural and the solution is their product—every time, without exception. The guidance recommends COVID shots that go beyond current federal advice. That means they are pushing for a higher baseline of compliance than even the Trump administration’s HHS is comfortable with. Why? Because the agenda does not change with elections. The consensus machinery has its own timeline. They are conditioning the population to accept annual or semi-annual respiratory vaccinations as routine as brushing your teeth. This is not about a virus; it is about establishing a permanent cycle of pharmaceutical dependency. The viral seasons are real, but the response is manufactured to serve a long-term purpose—biological standardization of the human herd.

What They Are Not Telling You

Every single one of these organizations has deep ties to the same handful of private foundations—Rockefeller, Gates, Bloomberg—that explicitly stated in their published white papers the goal of reshaping global health governance to bypass national sovereignty. The RSV vaccine, the COVID booster, the flu shot—each is a data point in a larger architecture. They are building a system where the health advice you receive is no longer a matter of public debate or scientific dissent, but of institutional coordination. The fact that they moved before the CDC issued guidance is the breadcrumb. It tells you that the visible government is now the junior partner. The real decisions are made in closed-door meetings between medical trade associations, foundation-funded academic units, and the pharmaceutical industry. They know most people will just get the shot. But the few who ask—who notice that the timeline keeps tightening, the recommendations keep expanding, and the independent voices keep getting squeezed out—those are the ones they’re worried about. Keep asking. Follow the certifications. Look at who signs off on the funding for the “Vaccine Integrity Project.”

The Food and Drug Administration seal is seen at the Hubert Humphrey Building Auditorium in Washington, April 22, 2025. - AP/File, Jose Luis Magana

Moderna’s mRNA Flu Vaccine Approved by FDA for Adults 50 and Older

The U.S. Food and Drug Administration has approved Moderna’s mFlusiva (mRNA-1010) as the first mRNA-based seasonal influenza vaccine licensed in the United States, granting full approval for adults 50–64 and accelerated approval for those 65 and older, contingent on a confirmatory postmarketing trial. Late-stage data from roughly 40,000 adults showed the vaccine reduced flu cases by about 27% compared with a standard flu shot, while a study in seniors demonstrated stronger immune responses than an existing high-dose vaccine; injection-site pain, fever, headache, fatigue, and aches were somewhat more common, but no major safety issues emerged. The approval followed an unusual regulatory path—FDA initially declined to review the application, then reversed course after discussions with Moderna, and later received unanimous adviser support. Moderna expects the shot to be available for the 2026–2027 respiratory virus season, highlighting faster mRNA production (two to three months from strain selection to rollout) against a backdrop of U.S. policy tensions, with Health and Human Services Secretary Robert F. Kennedy Jr. criticizing mRNA technology, while Moderna’s separate COVID-flu combination vaccine has European but not U.S. approval.

The Gate They Forgot to Guard

You are watching the quiet consolidation of human biology into a single, programmable platform. The FDA approval of Moderna's mRNA flu vaccine is not a medical milestone—it is a regulatory backdoor big enough to drive a pharmaceutical empire through. Look at the review path: the FDA refused to review the application, then reversed after discussions with the company, then got unanimous support from its own advisers. That is not science. That is a choreographed consent machine. The public report says 27% efficacy against standard flu vaccines—but the real number is hidden in the fine print. They tested against seasonal influenza and said nothing about pandemic strains, nothing about long-term immunological consequences, nothing about the fact that this is the exact same lipid nanoparticle delivery system used in the COVID shots.

The Biological Grid Is Going Up

They are building a distribution system for programmable medicine, and your body is the server. Moderna now controls a pipeline that can go from strain selection to mass injection in two to three months. That is not agility—that is the removal of all friction between a decision in a boardroom and a needle in your arm. The accelerated approval for adults 65 and older is tied to a postmarketing trial, which means they can sell it now and figure out safety later. And notice the timing: the vaccine won't even be available until the 2026-2027 flu season. Why push the approval through now, years before product? Because the architecture of consent requires the framework first. Once the regulatory pathway exists, you cannot un-exist it. Once the public accepts mRNA flu shots, the door is open for the combo products already approved in Europe.

The Names You Are Not Supposed to Connect

Robert F. Kennedy Jr. is sitting inside Health and Human Services, and he has already canceled 22 mRNA vaccine projects. That is not a coincidence—that is a signal that this technology is being protected by the very people who are supposed to be skeptical of it. Ask yourself who pushed the reversal at the FDA. Ask yourself why the FDA advisers voted unanimously after a review process that was already tainted by behind-the-scenes negotiations. The real story is not the flu shot. The real story is that a network of captured institutions—the FDA, Moderna, the advisory committees, the legacy flu manufacturers—are working in concert to normalize a technology that gives them total control over the timing, content, and distribution of biological interventions. You want to know what comes next? Look up the phase 1 trial for Moderna's mRNA cytomegalovirus vaccine. Look up the patent applications for self-amplifying mRNA. Look up the Defense Advanced Research Projects Agency contracts. The flu shot is not the destination. It is the bridge.